A Phase Ia Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Subcutaneously Administered CUG252 in Normal Healthy Volunteers
Clinical trial NCT05328557 · COMPLETED
Trial details
- NCT number
- NCT05328557
- Sponsor
- Cugene Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-11-09
- Primary completion
- 2022-08-03
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.